Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

NCT07243067 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07243067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07243067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
April 30, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chromophobe renal cell carcinoma, clear-cell renal cell carcinoma, kidney cancer, papillary renal cell carcinoma, renal cell carcinoma